Cite
Matsuba I, Takuma T, Hatori N, et al. Study on Continuation of Antibody Prevalence Six Months after Detection of Subclinical Severe Acute Respiratory Syndrome Coronavirus 2 Infections. Intern Med. 2021;61(2):159-165doi: 10.2169/internalmedicine.8019-21.
Matsuba, I., Takuma, T., Hatori, N., Takai, M., Watanabe, Y., Takada, N., Kishi, S., Matsuzawa, Y., Nishikawa, T., Kunishima, T., Degawa, H., Nishikawa, M., Ono, Y., & Kanamori, A. (2022). Study on Continuation of Antibody Prevalence Six Months after Detection of Subclinical Severe Acute Respiratory Syndrome Coronavirus 2 Infections. Internal medicine (Tokyo, Japan), 61(2), 159-165. https://doi.org/10.2169/internalmedicine.8019-21
Matsuba, Ikuro, et al. "Study on Continuation of Antibody Prevalence Six Months after Detection of Subclinical Severe Acute Respiratory Syndrome Coronavirus 2 Infections." Internal medicine (Tokyo, Japan) vol. 61,2 (2022): 159-165. doi: https://doi.org/10.2169/internalmedicine.8019-21
Matsuba I, Takuma T, Hatori N, Takai M, Watanabe Y, Takada N, Kishi S, Matsuzawa Y, Nishikawa T, Kunishima T, Degawa H, Nishikawa M, Ono Y, Kanamori A. Study on Continuation of Antibody Prevalence Six Months after Detection of Subclinical Severe Acute Respiratory Syndrome Coronavirus 2 Infections. Intern Med. 2022 Jan 15;61(2):159-165. doi: 10.2169/internalmedicine.8019-21. Epub 2021 Nov 06. PMID: 34744105.
Copy
Download .nbib